Previous 10 | Next 10 |
2024-03-17 09:50:00 ET There are many ways to spend $1,000. One could buy a brand-new flat-screen television, play the lottery, or keep it in a savings account. For people trying to increase their capital, though, investing in stocks easily beats out all three of those options -- provided, ...
2024-03-17 09:00:00 ET Investors can be procrastinators. It's easy to get caught up in analyzing stocks so much that people put off buying them. But that doesn't have to be the case. Three Motley Fool contributors have identified unstoppable stocks they think you can buy now without any...
2024-03-17 08:54:00 ET One "Magnificent Seven" stock that isn't looking so magnificent these days is Tesla (NASDAQ: TSLA) . Shares of the electric vehicle (EV) maker are down around 30% this year as price cuts for its vehicles have resulted in lower margins for the business, and con...
2024-03-14 07:20:30 ET More on WuXi AppTec, WuXi AppTec, etc. Potential U.S. Targeting Casts Shadow Over WuXi AppTec Family WuXi Biologics: Recent Share Price Recovery Isn't Sustainable Historical earnings data for WuXi AppTec Dividend scorecard for WuXi AppT...
2024-03-11 23:14:04 ET Vertex Pharmaceuticals Incorporated (VRTX) Leerink Partners Global Biopharma Conference Call March 11, 2024 16:00 ET Company Participants Charlie Wagner - Executive Vice President & Chief Financial Officer David Altshuler - Chief Scientific...
2024-03-10 13:00:53 ET More on the markets S&P 500: Time To Hedge, Here's How How The S&P 500 Could Actually Be Closer To 4,200 Than 5,000 SPDR S&P 500 ETF And Invesco QQQ Trust: Almost All Investors Are Crowded Into The Same Side Of The Boat Cata...
2024-03-05 14:59:57 ET More on Communication Services Select Sector SPDR Fund XLC: The Time To Buy Is Now Paramount, Live Nation most shorted S&P 500 communications stocks in end-January; Alphabet least shorted Communication Services, Info Tech and Healthcare jum...
2024-03-05 14:52:03 ET Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 44th Annual Health Care Conference Call March 5, 2024 10:30 ET Company Participants David Altshuler - Executive Vice President, Research and Chief Scientific Officer Charlie Wagner - Executive...
2024-03-05 09:30:00 ET It's not always a good idea to chase trends in a bull market, but sometimes the new wave of promising companies is more than a fad. In the biotech and pharma industries, right now is an exciting time, and there's reason to believe that the popular players of today wil...
2024-03-02 09:30:00 ET You can find growth stocks in every sector. With healthcare making up nearly one-fifth of the U.S. economy, it's a great place to look. Three Motley Fool contributors have identified what they think are magnificent growth stocks to buy in March -- and all of them ...
News, Short Squeeze, Breakout and More Instantly...
Vertex Pharmaceuticals Incorporated Company Name:
VRTX Stock Symbol:
NASDAQ Market:
- KALYDECO ® is the first and only medicine approved in the EU in this age group to treat the underlying cause of cystic fibrosis for specific mutations in the CFTR gene - Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has gra...
2024-04-25 09:45:00 ET While some stocks have responded to the 2024 bull market better than others, an abundance of stocks have followed this rising tide. There's no predicting how long this next bull market will last, although historically speaking, these periods tend to significantly outl...
2024-04-23 06:05:00 ET Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic fibrosis (CF). The biotech is the market leader, bringing in billions of dollars in revenue and profit annually from its CF drugs. And that's likely to continue than...